EDSA
Edesa Biotech Inc
NASDAQ: EDSA · HEALTHCARE · BIOTECHNOLOGY
$18.28
+14.94% today
Updated 2026-04-30
Market cap
$64.51M
P/E ratio
—
P/S ratio
130,462.29x
EPS (TTM)
$-1.07
Dividend yield
—
52W range
$1 – $12
Volume
5.6M
Edesa Biotech Inc (EDSA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-37667.00 | $-732227.00 | $-2.62M | $-3.95M | $-2.92M | $-4.27M | $-4.41M | $-4.51M | $-4.70M | $-4.62M | $-4.85M | $-4.99M | $-13.66M | $-12.28M | $-6.64M | $-4.89M | $-7.32M |
| Capital expenditures | $0.00 | $88877.00 | $309782.00 | $78338.00 | $9541.00 | $279065.00 | $274589.00 | $402271.00 | $302733.00 | $382810.00 | $8095.00 | $34339.00 | $6146.00 | $5656.00 | $3.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $43000.00 | $340122.00 | $4.01M | $1.92M | $627025.00 | $956634.00 | $267222.00 | $259379.00 | $115546.00 | $154313.00 | $46508.00 | $598359.00 | $3.20M | $2.26M | $1.25M | $537492.00 | $729642.00 |
| Free cash flow | $-37667.00 | $-821104.00 | $-2.93M | $-4.03M | $-2.93M | $-4.55M | $-4.69M | $-4.91M | $-5.00M | $-5.00M | $-4.85M | $-5.02M | $-13.67M | $-12.28M | $-6.64M | $-4.89M | $-7.32M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |